PharmaNet Development Group,

Inc., a provider of clinical development services to innovative

pharmaceutical, biotechnology, generic drug and medical device companies,

announced today that George A. McMillan has joined the Company as Chief

Financial Officer.

"We are pleased to have George join PharmaNet Development Group,"

commented Jeffrey P. McMullen, President and Chief Executive Officer. "He has

proven experience in successfully driving financial management strategies and

productivity improvement initiatives for both public and private


Mr. McMillan joins PharmaNet Development Group from Ze-Gen, Inc., a

Boston-based renewable energy company, where he filled the dual role of Chief

Operating Officer and Chief Financial Officer. Previously, George held the

position of Chief Financial Officer, Chief Executive Officer, and Chief

Operating Officer at diversified technology and services firms, including The

Palladium Group, Inc., CMGI, Inc., BMG Direct (Bertelsmann A.G.), Renaissance

Solutions, Eastern Exclusives and others.

Mr. McMillan has an A.B. in Economics from Stanford University and

received his J.D. and M.B.A. from Harvard University.